Riproximin , a novel type ii ribosome-inactivating protein...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/29 (2006.01) A61K 36/18 (2006.01) A61K 38/16 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 14/415 (2006.01) C07K 16/16 (2006.01) C07K 19/00 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01)

Patent

CA 2596514

Described is a novel type II ribosome-inactivating protein, riproximin, as well as nucleic acid molecules encoding said protein. Furthermore, therapeutic uses of riproximin are described.

L'invention concerne une nouvelle protéine inactivant les ribosomes de type II, la riproximine, ainsi que des molécules d'acide nucléique codant ladite protéine. L'invention concerne en outre des utilisations thérapeutiques de la riproximine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Riproximin , a novel type ii ribosome-inactivating protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Riproximin , a novel type ii ribosome-inactivating protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Riproximin , a novel type ii ribosome-inactivating protein... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1411431

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.